Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Buyse, 2007, Progression-free survival is a surrogate for survival in advanced colorectal cancer, J Clin Oncol, 25, 5218, 10.1200/JCO.2007.11.8836
Mody, 2018, Clinical trials and progress in metastatic colon cancer, Surg Oncol Clin N Am, 27, 349, 10.1016/j.soc.2017.11.008
Brocken, 2012, The faster the better? A systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways, Psychooncology, 21, 1, 10.1002/pon.1929
Xu, 2013, Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis, Ann Oncol, 24, 96, 10.1093/annonc/mds234
Duo, 2013, Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis, Clin Nucl Med, 38, 343, 10.1097/RLU.0b013e3182817af3
Li, 2014, Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis, Eur J Radiol, 83, 338, 10.1016/j.ejrad.2013.11.017
Liu, 2011, Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? A meta-analysis, Clin Oncol (R Coll Radiol), 23, 350, 10.1016/j.clon.2010.10.002
Wu, 2011, Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis, J Magn Reson Imaging, 34, 128, 10.1002/jmri.22608
Yang, 2011, Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy, Eur Radiol, 21, 2604, 10.1007/s00330-011-2221-4
Qu, 2012, A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer, Eur J Radiol, 81, 1007, 10.1016/j.ejrad.2011.01.126
Wu, 2013, Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: a meta-analysis, Surg Oncol, 22, 261, 10.1016/j.suronc.2013.10.004
Smets, 2018, Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review, Pediatr Radiol, 48, 241, 10.1007/s00247-017-4013-8
Peerlings, 2016, The diagnostic value of MR imaging in determining the lymph node status of patients with non-small cell lung cancer: a meta-analysis, Radiology, 281, 86, 10.1148/radiol.2016151631
Shen, 2016, Performance of DWI in the nodal characterization and assessment of lung cancer: a meta-analysis, AJR Am J Roentgenol, 206, 283, 10.2214/AJR.15.15032
Wu, 2012, Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?, J Surg Res, 178, 304, 10.1016/j.jss.2012.03.074
Squillaci, 2008, Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience, Abdom Imaging, 33, 676, 10.1007/s00261-007-9347-5
Taylor, 2017, Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L), BMC Cancer, 17, 299, 10.1186/s12885-017-3281-x
Ferrante di Ruffano, 2012, Assessing the value of diagnostic tests: a framework for designing and evaluating trials, BMJ, 344, e686, 10.1136/bmj.e686
Taylor, 2019, Diagnostic accuracy of whole-body magnetic resonance imaging versus standard imaging pathways for metastatic disease in newly diagnosed non-small cell lung cancer: the prospective Streamline L trial, Lancet Respir Med, 10.1016/S2213-2600(19)30090-6
2010
Ohno, 2008, Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT, Radiology, 248, 643, 10.1148/radiol.2482072039
Rutjes, 2007, Evaluation of diagnostic tests when there is no gold standard. A review of methods, Health Technol Assess, 11, 50, 10.3310/hta11500
Evans, 2018, Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations, Br J Radiol, 91, 20170731, 10.1259/bjr.20170731
Evans, 2017, Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study, BMJ Open, 7, e016391, 10.1136/bmjopen-2017-016391
Miles, 2019, Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment, Eur Radiol, 10.1007/s00330-019-06153-4
Alonzo, 2002, Sample size calculations for comparative studies of medical tests for detecting presence of disease, Stat Med, 21, 835, 10.1002/sim.1058
Newcombe, 1998, Improved confidence intervals for the difference between binomial proportions based on paired data, Stat Med, 17, 2635, 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C
Niekel, 2010, Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment, Radiology, 257, 674, 10.1148/radiol.10100729
Hunter, 2016, Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging, Br J Radiol, 10.1259/bjr.20160257
Kubo, 2019, Vendor free basics of radiation dose reduction techniques for CT, Eur J Radiol, 110, 14, 10.1016/j.ejrad.2018.11.002